Therefore, this emerging and promising biomarker has shown a more prominent correlation not only with insulin resistance than the evaluation of leptin and adiponectin alone has, but also demonstrates a remarkable reduction compared to the higher number of metabolic risk factors [41]. The gene discussed is LEP; the disease is Insulin resistance.